We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+3.38%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$43.8B
AUM Growth
-$4B
(-8.4%)
Cap. Flow
-$2.6B
Cap. Flow
% of AUM
-5.95%
Top 10 Holdings %
Top 10 Hldgs %
10.61%
Holding
2,617
New
198
Increased
927
Reduced
931
Closed
480
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$168M |
| 2 |
AbbVie
ABBV
|
+$164M |
| 3 |
TSMC
TSM
|
+$147M |
| 4 |
Amgen
AMGN
|
+$139M |
| 5 |
Walmart Inc
WMT
|
+$121M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$186M |
| 2 |
AGN
Allergan Inc
AGN
|
+$175M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$175M |
| 4 |
HCBK
HUDSON CITY BANCORP INC
HCBK
|
+$172M |
| 5 |
TQNT
TRIQUINT SEMICONDUCTOR INC
TQNT
|
+$164M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.89% |
| 2 | Technology | 16.32% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.57% |
| 5 | Industrials | 10.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRTU
1326
DELISTED
Virtusa Corporation
VRTU
| $1.23M | ﹤0.01% |
29,637
-16,100
| -35% | -$641K |
|
1327
The Greenbrier Companies
GBX
$1.43B
| $1.23M | ﹤0.01% |
21,124
-5,376
| -20% | -$297K |
|
1328
Safety Insurance
SAFT
$1.52B
| $1.22M | ﹤0.01% |
20,404
+10,475
| +105% | +$643K |
|
1329
Scansource
SCSC
$1.1B
| $1.22M | ﹤0.01% |
29,979
-20,300
| -40% | -$769K |
|
|
ECYT
1330
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $1.22M | ﹤0.01% |
194,000
-18,100
| -9% | -$104K |
|
1331
Pool Corp
POOL
$7.27B
| $1.21M | ﹤0.01% |
17,399
+13,700
| +370% | +$915K |
|
1332
Blackbaud
BLKB
$2.09B
| $1.21M | ﹤0.01% |
25,600
+16,200
| +172% | +$728K |
|
|
LTRPA
1333
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $1.21M | ﹤0.01% |
38,000
-81,991
| -68% | -$2.37M |
|
1334
Hexcel
HXL
$7.63B
| $1.21M | ﹤0.01% |
23,450
+7,700
| +49% | +$353K |
|
1335
Core Laboratories
CLB
$561M
| $1.2M | ﹤0.01% |
11,500
+8,200
| +248% | +$874K |
|
1336
Pegasystems
PEGA
$5.43B
| $1.2M | ﹤0.01% |
110,000
-25,400
| -19% | -$262K |
|
1337
Travere Therapeutics
TVTX
$5.74B
| $1.2M | ﹤0.01% |
49,900
+9,300
| +23% | +$142K |
|
|
SVC
1338
Service Properties Trust
SVC
$1.05B
| $1.19M | ﹤0.01% |
7,271
-3,484
| -32% | -$556K |
|
1339
Vermilion Energy
VET
$1.75B
| $1.19M | ﹤0.01% |
28,200
-124,600
| -82% | -$5.47M |
|
1340
Marcus & Millichap
MMI
$1.16B
| $1.18M | ﹤0.01% |
31,400
+18,800
| +149% | +$671K |
|
|
EXAM
1341
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
| $1.17M | ﹤0.01% |
28,161
-800
| -3% | -$32.2K |
|
|
EVER
1342
DELISTED
Everbank Financial Corp
EVER
| $1.17M | ﹤0.01% |
64,951
-22,871
| -26% | -$412K |
|
|
AMED
1343
DELISTED
Amedisys
AMED
| $1.17M | ﹤0.01% |
43,631
+17,455
| +67% | +$492K |
|
|
LABL
1344
DELISTED
Multi-Color Corp
LABL
| $1.17M | ﹤0.01% |
16,826
+4,282
| +34% | +$272K |
|
1345
Huron Consulting
HURN
$2.42B
| $1.17M | ﹤0.01% |
17,627
-3,108
| -15% | -$218K |
|
|
LMNX
1346
DELISTED
Luminex Corp
LMNX
| $1.17M | ﹤0.01% |
72,800
+41,700
| +134% | +$700K |
|
|
MACK
1347
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $1.16M | ﹤0.01% |
12,443
-686
| -5% | -$58.4K |
|
1348
Olin
OLN
$2.15B
| $1.16M | ﹤0.01% |
36,224
-46,923
| -56% | -$1.26M |
|
1349
Tilly's
TLYS
$130M
| $1.16M | ﹤0.01% |
+74,200
| New | +$990K |
|
|
ROIC
1350
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $1.16M | ﹤0.01% |
63,300
+19,000
| +43% | +$334K |
|
Similar funds
VGA
AQR Capital Management's Q1 2015 Portfolio in Review
As of Q1 2015, AQR Capital Management held 2,617 positions worth $43.8B, down 8.4% from $47.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
AQR Capital Management withdrew a net $2.6B in Q1 2015, closing 480 positions and reducing 931 holdings. Its most notable exit was Allergan Inc, an estimated $175M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, AQR Capital Management opened a new position in Qorvo worth $68.6M.
- AQR Capital Management's largest Q1 2015 buy was Qorvo: 860,877 shares worth $68.6M.
- AQR Capital Management added most to Microsoft in Q1 2015, an estimated $168M increase.
- AQR Capital Management's biggest Q1 2015 reduction was TIME WARNER CABLE INC NEW COM STK, cutting an estimated $186M.
- AQR Capital Management fully exited Allergan Inc in Q1 2015, selling an estimated $175M.
- AQR Capital Management's ten largest holdings make up 11% of its $43.8B portfolio in Q1 2015.
- AQR Capital Management opened 198 new positions and closed 480 in Q1 2015.
- AQR Capital Management's portfolio value fell 8.4% quarter-over-quarter to $43.8B.
Based on AQR Capital Management's 13F filing for Q1 2015, filed 15 May 2015.